-
[文献書誌] Ouchi N, et al.: "Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages"Circulation. 103. 1057-1063 (2001)
-
[文献書誌] Hotta K, et al.: "Circulating concentrations of the adipocyte protein, adiponectin, are decreased in parallel with reduced insulin sensitivity during the progression to type-2 diabetes in rhesus monkeys"Diabetes. 50. 1126-1133 (2001)
-
[文献書誌] Weyer C, et al.: "Hypoadiponectinemia in obesity and type 2 diabetes : Evidence for a role of insulin resistance and/or hyperinsulinemia"J. Clin. Endocrinol.Metab.. 86. 1930-1935 (2001)
-
[文献書誌] Maeda N, et al.: "PPARγ ligands increase expression and plasma concentrations of adiponectin an adipose-derived protein"Diabetes. 50. 2094-2099 (2001)
-
[文献書誌] Comuzzie AG, et al.: "The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome"J. Clin. Endocrinol. Metab.. 86. 4321-4325 (2001)
-
[文献書誌] Yang WS, et al.: "Weight reduction increases plasma levels of an adipose-derived antiinflammatory protein, adiponectin"J. Clin. Endocrinol. Metab.. 86. 3815-3819 (2001)
-
[文献書誌] Halleux CM, et al.: "Secretion of Adiponectin and Regulation of apMl Gene Expression in Human Visceral Adipose Tissue"Biochem Biophys Res Commun.. 288. 1102-1107 (2001)
-
[文献書誌] Nakamura T, et al.: "Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation-double-blind placebo-controlled trial"Diabetes Res Clin Pract.. 54. 181-190 (2001)
-
[文献書誌] Nagaretani H, et al.: "Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance"Diabetes Care.. 24. 2127-2133 (2001)
-
[文献書誌] Zoccali C, et al.: "Adiponectin, the most abundant adipocyte-derived protein, is functionally related to metabolic risk factors and predicts cardiovascular outcomes in end stage renal disease"J Am Soc Nephrol.. 13. 134-141 (2002)
-
[文献書誌] Yang WS, et al.: "Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients"Diabetes Care.. 25. 376-380 (2002)